| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | fentanyl (Instanyl®) single-dose |
| Formulation | 50 micrograms, 100 micrograms and 200 micrograms nasal spray |
| Reference number | 1424 |
| Indication | Management of breakthrough pain in adults already receiving maintenance opioid therapy for chronic cancer pain |
| Company | Nycomed UK Ltd |
| BNF chapter | Central nervous system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 21/10/2011 |